ELDN NASDAQ
Eledon Pharmaceuticals, Inc.
1W: -6.0%
1M: -16.7%
3M: -37.3%
YTD: +53.7%
1Y: -6.4%
3Y: +97.6%
5Y: -62.6%
$2.49
+0.06 (+2.26%)
Weekly Expected Move ±6.9%
$2
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-10-30
Earliest Filing
2025-11-13
Latest Filing
partner: 2
Counterparties (Filed by ELDN)
2 relationshipsCompanies named in ELDN's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leerink Partners, LLC | — | partner | Underwriter representative for the public offering of common stock and pre-funded warrants. | 2025-11-13 | View |
| Leerink Partners LLC | — | partner | Underwriter representative for the offering of common stock and pre-funded warrants. | 2024-10-30 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-06-22 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-01-02 | Unregistered Sales of Equity Securities; Financial Statements and Exhibits | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-13 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-11-07 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Non-Reliance on Previously Issued Financial Statement | View | |
| 2025-08-06 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-06-12 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-05-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-14 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-04-07 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-12-20 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-30 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2024-10-29 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-10-01 | Unregistered Sales of Equity Securities | View | |
| 2024-08-14 | Results of Operations and Financial Condition; Non-Reliance on Previously Issued Financial Statement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR